However, this aspect could not explain the improved prognostic outcome of patients whose tumor tissues stained positively for PD-L1 expression in assays using the 22C3 antibody, and higher AUC values in the survival model with PD-L1 expression based on the 22C3-IHC assay. This evidence concerns the gene CD274 and neoplasm.